Pharma Journalist - Page 723 of 937 -

Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy

Lonza Secures Nona’s BBB Technology for CNS Drug Development

Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment

Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302

Abzena Signs Protein Engineering Agreement with NYU Langone Health

Selumetinib granted orphan designation in Europe for neurofibromatosis type 1

Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island

Akcea and PTC Collaborate to Commercialize Two Rare Disease Drugs in Latin America

PRIME designation granted by EMA for RG6042 for treatment of Huntington’s disease

Novartis marks a new era for migraine patients with the EU approval of Aimovig

Selumetinib granted orphan designation in Europe for neurofibromatosis type 1

Takeda to Produce Innovative Drug for Multiple Myeloma Patients in Yaroslavl, Russia

Pfizer Receives European Approval for Oncology Biosimilar, TRAZIMERA (trastuzumab)